Nantahala Capital Management’s Soleno Therapeutics SLNO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $83.9M | Sell |
|
|||||
|
2025
Q1 | $126M | Sell |
|
|||||
|
2024
Q4 | $177M | Buy |
|
|||||
|
2024
Q3 | $165M | Buy |
|
|||||
|
2024
Q2 | $126M | Buy |
|
|||||
|
2024
Q1 | $103M | Sell |
|
|||||
|
2023
Q4 | $115M | Buy |
|
|||||
|
2023
Q3 | $11.6M | Sell |
|
|||||
|
2023
Q2 | $2.79M | Sell |
|
|||||
|
2023
Q1 | $1.5M | Buy |
|
|||||
|
2022
Q4 | $1.2M | Hold |
|
|||||
|
2022
Q3 | $1.01M | Sell |
|
|||||
|
2022
Q2 | $1.68M | Hold |
|
|||||
|
2022
Q1 | $2.1M | Sell |
|
|||||
|
2021
Q4 | $4M | Hold |
|
|||||
|
2021
Q3 | $9.03M | Hold |
|
|||||
|
2021
Q2 | $11.1M | Buy |
|
|||||
|
2021
Q1 | $9.85M | Sell |
|
|||||
|
2020
Q4 | $15.2M | Buy |
|
|||||
|
2020
Q3 | $18.6M | Hold |
|
|||||
|
2020
Q2 | $16.5M | Buy |
|
|||||
|
2020
Q1 | $10.2M | Hold |
|
|||||
|
2019
Q4 | $12.6M | Buy |
|